Alexander J. Denner, a director of Ironwood Pharmaceuticals Inc (NASDAQ:IRWD), sold shares of the company's Class A Common Stock on March 17, 2026, for proceeds totaling $20.5 million, according to a Form 4 filed with the Securities and Exchange Commission.
The disposition was carried out in two separate blocks. Denner sold 6,725,000 shares at $3.05 per share and an additional 5,800 shares at $3.31 per share. The combined sales on that date produced the $20.5 million figure disclosed in the SEC filing.
The timing of Denner's sale coincides with heightened near-term movement in the stock. Ironwood's shares declined nearly 12% over the prior week, though the share price remained up 124% over the preceding 12 months as noted in the filing and company disclosures.
Separately, the filing records that on March 13, 2026, Denner acquired 4,451 shares of Class A Common Stock at no cost. Those shares were issued under the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024.
After accounting for the March transactions, Denner retains indirect holdings of 9,188,635 shares through Sarissa Capital Management LP and related funds. The filing states that Denner disclaims beneficial ownership of those shares except to the extent of his pecuniary interest.
Company financials and analyst moves
Ironwood reported its fourth-quarter 2025 results showing an EPS loss of $0.01, below the expected loss of $0.02, and revenue of $47.71 million, under the forecast of $62.43 million. The company disclosed fourth-quarter Linzess U.S. net sales of $163.2 million and total revenue for the quarter of $47.7 million. For the full year 2025, Linzess sales reached $864.5 million and total revenue was $296.2 million.
Following the results, Jefferies raised its price target on Ironwood to $3.70 from $0.70 and maintained a Hold rating, while increasing its Linzess peak sales estimate to $478 million. Citizens also adjusted its price target upward to $10.00 from $8.00 and maintained a Market Outperform rating, citing the company's reiterated 2026 guidance and confidence in Linzess cash-flow generation.
Ironwood reaffirmed its 2026 guidance, including adjusted EBITDA exceeding $300 million. In addition, an SEC filing indicated the company confirmed it met the liquidity conditions required under its existing Credit Agreement and notified Wells Fargo Bank, the administrative agent for that agreement, that it satisfied the outlined liquidity requirements.
Context and implications
The Form 4 disclosure documents the mechanics and scale of Denner's March 17 transactions and the March 13 award under the company's director compensation policy. The filing also clarifies Denner's indirect position through Sarissa Capital Management LP and related funds.
Investors and market participants reviewing insider activity, company results, analyst updates, and credit-agreement status will find the filings and disclosures relevant to assessing near-term market behavior for IRWD shares. The company continues to provide guidance for 2026 while publicly confirming compliance with its credit agreement's liquidity terms.